Incidence of paraproteinemic keratopathy in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma und multiple myeloma
Recruiting
- Conditions
- D47.2C90.01Monoclonal gammopathy of undetermined significance (MGUS)
- Registration Number
- DRKS00023893
- Lead Sponsor
- Klinik und Poliklinik für Augenheilkunde der Universitätsmedizin Mainz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients diagnosed with monoclonal gammopathy of unclear significance (MGUS), smoldering multiple myeloma (SMM) or multiple myeloma (MM)
men and women
- Age = 18 years
- The patient is able to participate in the course of the study
- The patient is able to give consent and has consented to participate in the study.
Exclusion Criteria
- Condition after bilateral refractive corneal surgery (e.g. LASIK, LASEK, PTK)
- Patients with no measurable M protein in urine or serum
- Patients with asecretory multiple myeloma
- plasma cell leukemia
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Description of the prevalence of paraproteinemic keratopathy
- Secondary Outcome Measures
Name Time Method Interrelation between the ophthalmological and hematological findings in paraproteinemic keratopathy